Cuba's forthcoming vaccine can treat lung cancer

On 8/9 medicalxpress page reported that patients with end-stage lung cancer are about to be equipped with a therapeutic tool again when Cuban health authorities announced that they are about to launch the first lung cancer vaccine in the world. gender.

On 8/9 medicalxpress page reported that patients with end-stage lung cancer are about to be equipped with a therapeutic tool again when Cuban health authorities announced that they are about to launch the first lung cancer vaccine in the world. gender.

>>>Cuba sells cancer medicines from green scorpion venom
>>> Technology makes cancer automatically "show the whole picture"

The vaccine, called CimaVax EGF, is intended for patients with third and fourth stage lung cancer but has not progressed with other treatments such as chemotherapy and radiation therapy.

"This vaccine can turn cancer into a manageable chronic disease, by creating antibodies against proteins that cause uncontrolled cell growth. Although it is not a deterrent. The disease, but the vaccine significantly improves the health of patients who are seriously ill, "said Gisela Gonzalez of the Molecular Immunology Center (CIM) in Havana.

Picture 1 of Cuba's forthcoming vaccine can treat lung cancer

The research group has conducted clinical research and testing on more than 1,000 lung cancer patients in Cuba, where the vaccine is free.

Because Cuba has many smokers, lung cancer is the leading cause of death in 12 of the 15 provinces in the country.

The above lung cancer vaccine is the result of a 25-year study of CIM scientists on smoking-related diseases.

In the future, researchers plan to apply the same principles of CimaVAX-EGF vaccine to treat other cancerous tumors, such as prostate, uterine, and breast cancer.

According to the World Health Organization, lung cancer is the most common and dangerous cancer, causing 1.4 million deaths worldwide each year.

Although current treatments can improve the survival rate for cancer patients when detected early, but for patients with end-stage lung cancer, the 5-year survival rate is less than full. first%.

Update 14 December 2018
« PREV
NEXT »
Category

Technology

Life

Discover science

Medicine - Health

Event

Entertainment